1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ionis Pharmaceuticals Inc (IONS)
  7. News

IONS

Ionis Pharmaceuticals News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Ionis Pharmaceuticals Inc IONS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.71 -2.39% 29.05 17:00:01
Open Price Low Price High Price Close Price Prev Close
29.86 28.885 30.27 29.05 29.76
more quote information »

Recent News

Date Time Source Heading
11/26/20218:00IHNWFeaturedFor US to stand a chance in the global battery arms race, developing a graphite supply is a must.
11/26/202116:06EDGARCurrent Report Filing (8-k)
11/26/202108:16TRMNIonis Reveals Results study of vupanorsen
11/25/202104:10TRMNIonis Pharmaceuticals (IONS) Gets a Hold Rating from Leerink..
11/24/202109:30EDGARCurrent Report Filing (8-k)
11/24/202107:29DJNIonis Pharma: Clinical Study of Vupanorsen Meets Primary..
11/24/202107:20SEEKIonis says that Pfizer reports topline results from Phase 2b..
11/24/202106:30PRNUSIonis announces that Pfizer reports topline results from..
11/18/202113:30PRNUSIonis initiates Phase 3 clinical program of donidalorsen in..
11/12/202107:05PRNUSIonis' antisense therapies to be featured at the American..
11/09/202107:05PRNUSIonis to present at upcoming virtual investor conferences
11/07/202107:05PRNUSPhase 2 study results of Ionis' novel antisense treatment..
11/03/202115:38EDGARQuarterly Report (10-q)
11/03/202108:54SEEKIonis sees Q3 net loss more than double due to restructured..
11/03/202107:05SEEKIonis Pharmaceuticals EPS misses by $0.05, misses on revenue
11/03/202107:00PRNUSIonis reports third quarter 2021 financial results and..
11/02/202111:33SEEKIonis Pharmaceuticals Q3 2021 Earnings Preview
11/02/202107:16SEEKIonis initiates late-stage olezarsen hypertriglyceridemia..
11/02/202107:05PRNUSIonis initiates pivotal Phase 3 clinical study of olezarsen..
10/20/202107:05PRNUSIonis to hold third quarter 2021 financial results webcast
10/19/202118:30EDGARStatement of Changes in Beneficial Ownership (4)
10/19/202118:30EDGARStatement of Changes in Beneficial Ownership (4)
10/19/202118:29EDGARStatement of Changes in Beneficial Ownership (4)
10/18/202114:31EDGARCurrent Report Filing (8-k)
10/18/202110:55DJNIonis Pharma Shares Drop 12% After Tofersen Study Misses..
10/17/202116:20PRNUSIonis' partner Biogen provides update on tofersen Phase 3..
10/14/202116:06GLOBETopline Results from Tofersen Phase 3 Study and its Open..
9/30/202110:54DJNVC Daily: Expansion Therapeutics Gets $80 Million for..
9/23/202115:34SEEKPTC Therapeutics slips after early stage results from..
9/15/202107:30GLOBEBiogen Plans to Initiate Phase 3b Study Evaluating Potential..
9/03/202107:05PRNUSIonis to host ATTR symposium highlighting CARDIO-TTRansform..
9/02/202119:26EDGARStatement of Changes in Beneficial Ownership (4)
9/02/202119:21EDGARStatement of Changes in Beneficial Ownership (4)
9/02/202119:21EDGARStatement of Changes in Beneficial Ownership (4)
9/02/202119:21EDGARStatement of Changes in Beneficial Ownership (4)
9/02/202119:21EDGARStatement of Changes in Beneficial Ownership (4)
9/02/202119:20EDGARStatement of Changes in Beneficial Ownership (4)
9/02/202107:05PRNUSIonis to present at upcoming virtual investor conferences
8/05/202117:00EDGARSecurities Registration: Employee Benefit Plan (s-8)
8/04/202107:04SEEKIonis Pharmaceuticals EPS in-line, misses on revenue
8/04/202107:00PRNUSIonis reports second quarter 2021 financial results and..
8/02/202110:14SEEKIonis provides enrollment update for Novartis' late-stage..
8/02/202109:30PRNUSLp(a) HORIZON achieves 50% enrollment in trial to assess the..
7/29/202107:47SEEKIonis completes enrollment in late-stage eplontersen..
7/29/202107:05PRNUSIonis completes enrollment in pivotal NEURO-TTRansform study..
7/26/202117:01SEEKBiogen and Ionis post promising data from early-stage..
7/26/202116:35PRNUSBiogen and Ionis report positive topline clinical data on..
7/21/202107:05PRNUSIonis to hold second quarter 2021 financial results webcast
7/13/202107:27SEEKIonis inks licensing deal with Bicycle Therapeutics to..
7/13/202106:59PRNUSIonis enters exclusive licensing agreement with Bicycle..
7/06/202117:53EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »


Your Recent History
NASDAQ
IONS
Ionis Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.